期刊文献+

乳酸水平对恶性肿瘤脓毒症/脓毒症休克患者不良预后的预测价值 被引量:2

Prognostic value of lactate level in cancer patients with sepsis/septic shock
下载PDF
导出
摘要 目的评估入急诊时乳酸水平对恶性肿瘤脓毒症/脓毒症休克患者预后的预测价值。方法本研究为回顾性事后分析,数据来自Abou Dagher等[5-6]已发表研究。回顾性收集急诊室最终诊断为脓毒症/脓毒症休克的恶性肿瘤患者176例,排除74例乳酸值缺失的患者,最终纳入102例患者。根据出院时生存状态分为生存组47例,死亡组55例。比较两组入急诊时的乳酸水平并分析患者预后的独立危险因素。结果纳入患者年龄多处于61~80岁,男性患者多于女性。其中73.5%的患者为实质性脏器肿瘤,26.5%为血液系统肿瘤。死亡组患者入急诊时乳酸水平较生存组增高[(5.45±3.74)mmol/L vs(3.06±1.99)mmol/L,P<0.01]。入急诊时乳酸水平预测恶性肿瘤脓毒症/脓毒症休克患者院内病死率的受试者工作特征曲线下面积(area under the receiver operating characteristic curves,AUC)为0.711(95%CI:0.613~0.796,P<0.01)。调整其他混杂因素后,入急诊时乳酸水平(OR=1.326,95%CI:1.026~1.714,P=0.031)和尿素氮水平(OR=1.038,95%CI:1.003~1.074,P=0.037)是预测恶性肿瘤脓毒症/脓毒症休克患者院内病死率的独立危险因素。结论早期乳酸水平可以作为判断恶性肿瘤脓毒症及脓毒性休克患者预后的一个重要指标。 Objective To evaluate the prognostic value of lactate level in cancer patients with sepsis/septic shock.Methods This study was a retrospective analysis with the data from a published study by Abou Daghter et al.One-hundred-and-seventy-six patients with cancer were diagnosed as sepsis/septic shock in the emergency department.After excluding 74 patients with no lactate data,102 patients were eventually included.According to the state of survival at discharge,47 patients were in the survival group and 55 patients in the death group.Lactate levels were compared between the two groups at emergency admission and independent risk factors for patient prognosis were analyzed.Categorical variables were compared usingχ2,adjustedχ2 or Fisher test.Quantitative variables were compared using Student's t test or non-parameter test.Results Most of the included patients were between 61 and 80 years old,and male patients were more than female patients.Among the included patients,73.5%were parenchymal organ tumors and 26.5%were with hematological tumors.The lactate level of the death group were significantly higher than that of the survival group[(5.45±3.74)mmol/L vs(3.06±1.99)mmol/L,P<0.01].The area under the receiver operating characteristic curve(AUC)of lactate level in predicting hospital-mortality was 0.711(95%CI:0.613-0.796,P<0.01).After adjusting for other confounding factors,the lactate level(OR=1.326,95%CI:1.026-1.714,P=0.031)and urea nitrogen level(OR=1.038,95%CI:1.003-1.074,P=0.037)were independently associated with hospital-mortality in cancer patients with sepsis/septic shock.Conclusion The early lactate level is useful in predicting the prognosis of cancer patients with sepsis/septic shock.
作者 冯霞 冷报浪 梁斌 杜康 Feng Xia;Leng Baolang;Liang Bin;Du Kang(Department of Respiratory Medicine,Hangzhou Third Hospital,Hangzhou 310009,China)
出处 《实用肿瘤杂志》 CAS 2019年第6期534-539,共6页 Journal of Practical Oncology
关键词 肿瘤/血液 脓毒症/血液 休克 脓毒性/血液 乳酸/血液 危险因素 预后 预测 回顾性研究 neoplasms/blood sepsis/blood shock,septic/blood lactic acid/blood risk factors prognosis forecasting retrospective studies
  • 相关文献

参考文献6

二级参考文献68

  • 1戴新贵,艾宇航,蔡业平,罗翠竹,张丽娜.脓毒性脑病的流行病学特点及高危因素分析[J].中国全科医学,2009,12(2):102-104. 被引量:12
  • 2苏磊,周殿元,唐柚青,文强,白涛,孟繁苏,唐丽群,段鹏凯.CD14^+单核细胞人白细胞DR抗原在脓毒症早期检测中的临床意义[J].中国危重病急救医学,2006,18(11):677-679. 被引量:21
  • 3戴新贵,艾宇航,刘志勇,张丽娜,罗翠竹.影响脓毒症预后的多因素分析[J].中国危重病急救医学,2008,20(1):49-51. 被引量:18
  • 4Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ ACCP/ATS/SIS International Sepsis Definitions Conference [ J ]. Crit Care Med,2003,31 (4) : 1250-1256.
  • 5Levy MM, Artigas A, Phillips GS, et al. Outcomes of the Surviving Sepsis Campaign in intensive care units in the USA and Europe : a prospective cohort study [ J ]. Lancet Infect Dis,2012,12 (12) : 919-924.
  • 6Bone RC, Fisher CJ Jr, Clemmer TP, et al. A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock [J]. N Engl J Med,1987,317(11): 653-658.
  • 7Fisher CJ Jr, Agosti JM, Opal SM, et al. Treatment of septic shock with the tumor necrosis factor receptor : Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group [ J ]. N Engl J Med, 1996,334 (26) : 1697-1702.
  • 8Fisher CJ Jr, Slotman GJ, Opal SM, et al. Initial evaluation of human recombinant interleukin-I receptor antagonist in the treatment of sepsis syndrome: a randomized, open-label, placebo-controlled muhicenter trial [ J ]. Crit Care Med, 1994, 22 (1) : 12-21.
  • 9Chong DL, Sriskandan S. Pro-inflammatory mechanisms in sepsis [ J ]. Contrib Microbiol,2011,17 : 86-107.
  • 10Otto GP, Sossdorf M, Claus RA, et al. The late phase of sepsis is characterized by an increased microbiological burden and death rate [ J ]. Crit Care,2011,15 (4) : R183.

共引文献299

同被引文献32

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部